DOI: http://dx.doi.org/10.18203/2349-3933.ijam20195653

Epidemiological and clinical study of sickle cell disease at tertiary care centre in Western India

Varsha P. Patel, Archana U. Gandhi, Chineen Shah

Abstract


Background: Sickle cell disorders are structural hemoglobinopathies, rendering red blood cells sickle shaped, less deformable and sticky leading to microvascular vaso-occlusion and premature red blood cells destruction which leads to varied clinical manifestations. It leads to lifelong morbidity thus affecting quality of life and contributes to early mortality thereby reducing the key national resources- the healthy workforce. This study was done to evaluate epidemiological and clinical profile of sickle cell disease attending the centre.

Methods: This study was cross-sectional, observational study conducted at tertiary care hospital in Gujarat. After taking ethical clearance patients were enrolled as per inclusion and exclusion criteria and epidemiological and clinical profile of sickle cell disease patients was studied.

Results: Mean age of sickle cell disease was 22.58 years. It was found in tribal communities of Gujarat like Rathwa, Baria, Tadvi etc. Commonest symptom was musculoskeletal pain (86.84%), followed by jaundice (71.05%), fever, dyspnoea, abdominal pain and chest pain. Most common systemic manifestation was pain crises (60.66%), followed by hemolytic anemia (31.15%), acute chest syndrome (30%), consolidation (11.67%), hepatopathy (10%) and avascular necrosis of hip. (6.56%).

Conclusions: Sickle cell disease is seen in younger patients. In Gujarat mainly tribal communities are affected. Major systemic manifestations of sickle cell disease include pain crisis followed by hemolytic crisis, acute chest syndrome, hepatopathy and AVN of hip.    


Keywords


Acute chest syndrome, Epidemiology, Hemoglobinopathies, Haemolytic anemia, Pain crises, Sickle cell disease

Full Text:

PDF

References


Edward J. Disordrs of Hemoglobin. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. Harrison’s principles of Internal Medicine. 19th Ed. NY: McGraw-Hill; 2015:631-639.

Bhatia HM, Rao VR. Genetic atlas of the Indian tribes. Institute of Immunohaematology, Ind Council Med Res; 1986.

Patel Ashwin P, Naik Madhuben R, Shah Nilam M, Sharma Narmadeshwar P, Parmar Prakash H. Prevalence of common hemoglobinopathies in Gujarat: an analysis of a large population screening program. Nat J Commu Med. 2012;3(1):112-6.

Ibidapo MO, Akinyanju OO. Acute sickle cell syndromes in Nigerian adults. Clini Lab Haematol. 2000 Jun;22(3):151-5.

Kar BC. Sickle cell disease in India. J Assoc Physic India. 1991 Dec;39(12):954-60.

Diop S, Mokono SO, Ndiaye M, Touré AF, Thiam D, Diakhate L. Homozygous sickle cell disease in patients above 20 years of age: follow-up of 108 patients in Dakar. La Revue Med Intern. 2003 Nov;24(11):711-5.

Yadav R, Gupta RB, Bharadwarj VK, Singh MP. Morbidity profile of sickle cell disease in central India. Proceed Nat Symposium Tribal Health. 2006:135-40.

Serjeant GR, Sommereux A, Stevenson M, Mason K, Serjeant BE. Comparison of sickle cell‐β° thalassaemia with homozygous sickle cell disease. Brit J Haematol. 1979 Jan;41(1):83-93.

Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The cooperative study of sickle cell disease. Blood. 1994 Jul 15;84(2):643-9.

Haberkern CM, Neumayr LD, Orringer EP, Earles AN, Robertson SM, Black D, et al. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Blood. 1997 Mar 1;89(5):1533-42.

Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease life expectancy and risk factors for early death. N Engl J Med. 1994 Jun 9;330(23):1639-44.

Marouf R, Gupta R, Haider MZ, Al-Wazzan H, Adekile AD. Avascular necrosis of the femoral head in adult Kuwaiti sickle cell disease patients. Acta Haematol. 2003;110(1):11-5.